Correction to: Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell Lymphoma
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:60 |
|---|---|
| Enthalten in: |
Clinical pharmacokinetics - 60(2021), 12 vom: 03. Juli, Seite 1635-1635 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ogasawara, Ken [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| RVK: |
|---|
| Anmerkungen: |
© The Author(s) 2021 |
|---|
| doi: |
10.1007/s40262-021-01055-5 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2077523573 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2077523573 | ||
| 003 | DE-627 | ||
| 005 | 20230512141234.0 | ||
| 007 | tu | ||
| 008 | 221220s2021 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s40262-021-01055-5 |2 doi | |
| 035 | |a (DE-627)OLC2077523573 | ||
| 035 | |a (DE-He213)s40262-021-01055-5-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 15,3 |2 ssgn | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 084 | |a XA 36894 |q VZ |2 rvk | ||
| 100 | 1 | |a Ogasawara, Ken |e verfasserin |0 (orcid)0000-0002-4264-8927 |4 aut | |
| 245 | 1 | 0 | |a Correction to: Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell Lymphoma |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © The Author(s) 2021 | ||
| 700 | 1 | |a Dodds, Michael |4 aut | |
| 700 | 1 | |a Mack, Timothy |4 aut | |
| 700 | 1 | |a Lymp, James |4 aut | |
| 700 | 1 | |a Dell’Aringa, Justine |4 aut | |
| 700 | 1 | |a Smith, Jeff |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical pharmacokinetics |d Springer International Publishing, 1976 |g 60(2021), 12 vom: 03. Juli, Seite 1635-1635 |w (DE-627)129450995 |w (DE-600)197627-8 |w (DE-576)014816253 |x 0312-5963 |7 nnns |
| 773 | 1 | 8 | |g volume:60 |g year:2021 |g number:12 |g day:03 |g month:07 |g pages:1635-1635 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s40262-021-01055-5 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 936 | r | v | |a XA 36894 |
| 951 | |a AR | ||
| 952 | |d 60 |j 2021 |e 12 |b 03 |c 07 |h 1635-1635 | ||